
ACADIA Pharmaceuticals Inc.: shareholders and insiders
Price
$17.83
November 18, 2026Market cap $3.0B
What Ploutos Investor adds for ACADIA Pharmaceuticals
Part of Ploutos Investor, €9.99 a month
- The full history: 17 fiscal years, from 2009
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
Notes on these figures
- Most of the reported profit is a tax credit, not money earned from customers. We leave out the P/E and the earnings growth, which would not compare with a company that paid tax.
Insiders and their shares
Purchases and sales by officers and directors from Nov 19, 2025 to Oct 30, 2026, from their own Form 4 filings.
Bought on the market
–
nobody
Sold on the market
$2.5M
5 people
From Nov 19, 2025 to Nov 19, 2026, the days the chart shows. Change its range and the figures follow.
How the sales were made, as a share of their value
- Under a set plan95%
- The rest5%
By year
Insiders' open-market purchases (up) and sales (down), by value, since Nov 19, 2025, on a log scale: each gridline is ten times the last. From the SEC's quarterly data sets of Form 4 filings.
2026·no buys·sold $2.5M by 5 people
- 2025: no buys, no sales
- 2026: no buys, sold $2.5M by 5 people
- Oct 30, 2026Mark C. SchneyerEVP, CHIEF FINANCIAL OFFICERKind10b5-1
- Oct 15, 2026Mark C. SchneyerEVP, CHIEF FINANCIAL OFFICERKind
- Aug 6, 2026Mark C. SchneyerEVP, CHIEF FINANCIAL OFFICERKind10b5-1
- Aug 6, 2026Mark C. SchneyerEVP, CHIEF FINANCIAL OFFICERKind10b5-1
- Aug 6, 2026Mark C. SchneyerEVP, CHIEF FINANCIAL OFFICERKind10b5-1
- Aug 5, 2026Mark C. SchneyerEVP, CHIEF FINANCIAL OFFICERKind10b5-1
- Aug 5, 2026Mark C. SchneyerEVP, CHIEF FINANCIAL OFFICERKind10b5-1
- Jul 30, 2026Elizabeth H.Z. ThompsonEVP, Head of Research & DevKind10b5-1
- Jul 30, 2026Elizabeth H.Z. ThompsonEVP, Head of Research & DevKind10b5-1
- Jul 29, 2026Elizabeth H.Z. ThompsonEVP, Head of Research & DevKind
- Jun 26, 2026James KiharaPRINCIPAL ACCOUNTING OFFICERKind10b5-1
- May 29, 2026Baker Bros. Advisors LpDirectorKind
- May 29, 2026Baker Bros. Advisors LpDirectorKind
- May 29, 2026Edmund HarriganDirectorKind
- May 29, 2026Adora NduDirectorKind
- May 29, 2026Laura BregeDirectorKind
- May 29, 2026Jonathan PooleDirectorKind
- May 29, 2026Elizabeth A. GarofaloDirectorKind
- May 29, 2026James M DalyDirectorKind
- May 26, 2026James KiharaPRINCIPAL ACCOUNTING OFFICERKind
- May 4, 2026James KiharaPRINCIPAL ACCOUNTING OFFICERKind10b5-1
- May 4, 2026Mark C. SchneyerEVP, CHIEF FINANCIAL OFFICERKind10b5-1
- Apr 7, 2026James KiharaPRINCIPAL ACCOUNTING OFFICERKind10b5-1
- Apr 7, 2026Mark C. SchneyerEVP, CHIEF FINANCIAL OFFICERKind10b5-1
- Mar 26, 2026James KiharaPRINCIPAL ACCOUNTING OFFICERKind10b5-1
| Date | Person | Kind | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Oct 30, 2026 | Mark C. SchneyerEVP, CHIEF FINANCIAL OFFICER | 10b5-1 | 3,321 | $20.88 | $69.3K | Form 4 |
| Oct 15, 2026 | Mark C. SchneyerEVP, CHIEF FINANCIAL OFFICER | 6,815 | – | – | Form 4 | |
| Aug 6, 2026 | Mark C. SchneyerEVP, CHIEF FINANCIAL OFFICER | 10b5-1 | 14.3K | $17.84 | $255.0K | Form 4 |
| Aug 6, 2026 | Mark C. SchneyerEVP, CHIEF FINANCIAL OFFICER | 10b5-1 | 5,000 | $29.00 | $145.0K | Form 4 |
| Aug 6, 2026 | Mark C. SchneyerEVP, CHIEF FINANCIAL OFFICER | 10b5-1 | 9,292 | $29.34 | $272.6K | Form 4 |
| Aug 5, 2026 | Mark C. SchneyerEVP, CHIEF FINANCIAL OFFICER | 10b5-1 | 5,849 | $17.84 | $104.3K | Form 4 |
| Aug 5, 2026 | Mark C. SchneyerEVP, CHIEF FINANCIAL OFFICER | 10b5-1 | 5,849 | $29.00 | $169.6K | Form 4 |
| Jul 30, 2026 | Elizabeth H.Z. ThompsonEVP, Head of Research & Dev | 10b5-1 | 16.5K | $26.13 | $431.4K | Form 4 |
| Jul 30, 2026 | Elizabeth H.Z. ThompsonEVP, Head of Research & Dev | 10b5-1 | 50 | $26.17 | $1.3K | Form 4 |
| Jul 29, 2026 | Elizabeth H.Z. ThompsonEVP, Head of Research & Dev | 32.3K | – | – | Form 4 | |
| Jun 26, 2026 | James KiharaPRINCIPAL ACCOUNTING OFFICER | 10b5-1 | 11.4K | $26.08 | $297.9K | Form 4 |
| May 29, 2026 | Baker Bros. Advisors LpDirector | 18.6K | – | – | Form 4 | |
| May 29, 2026 | Baker Bros. Advisors LpDirector | 18.6K | – | – | Form 4 | |
| May 29, 2026 | Edmund HarriganDirector | 8,107 | – | – | Form 4 | |
| May 29, 2026 | Adora NduDirector | 8,107 | – | – | Form 4 | |
| May 29, 2026 | Laura BregeDirector | 8,107 | – | – | Form 4 | |
| May 29, 2026 | Jonathan PooleDirector | 2,010 | – | – | Form 4 | |
| May 29, 2026 | Elizabeth A. GarofaloDirector | 8,107 | – | – | Form 4 | |
| May 29, 2026 | James M DalyDirector | 8,107 | – | – | Form 4 | |
| May 26, 2026 | James KiharaPRINCIPAL ACCOUNTING OFFICER | 5,401 | $21.18 | $114.4K | Form 4 | |
| May 4, 2026 | James KiharaPRINCIPAL ACCOUNTING OFFICER | 10b5-1 | 1,332 | $21.79 | $29.0K | Form 4 |
| May 4, 2026 | Mark C. SchneyerEVP, CHIEF FINANCIAL OFFICER | 10b5-1 | 3,506 | $21.79 | $76.4K | Form 4 |
| Apr 7, 2026 | James KiharaPRINCIPAL ACCOUNTING OFFICER | 10b5-1 | 1,030 | $22.20 | $22.9K | Form 4 |
| Apr 7, 2026 | Mark C. SchneyerEVP, CHIEF FINANCIAL OFFICER | 10b5-1 | 2,709 | $22.20 | $60.1K | Form 4 |
| Mar 26, 2026 | James KiharaPRINCIPAL ACCOUNTING OFFICER | 10b5-1 | 12 | $21.73 | $261 | Form 4 |
From the Form 4s insiders file with the SEC within two business days of each trade. Before May 27, 2026 the table lists open-market purchases and sales only (no grants, option exercises or tax withholding), from the SEC's quarterly data sets. The 10b5-1 mark comes from the form's own box (since April 2023) or from a footnote of the filing that names the plan, where there is one.
Insiders and their shares
Every buy and sale by ACAD's officers and directors from 2006 up to November 18, 2025, 20 more calendar years
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 3 years.
and 15 more, back to 2006
Major holders (over 5%)
Whoever comes to own more than 5% of a class of shares reports it to the SEC on Schedule 13D or 13G. Here is each holder's latest filing.
- Baker Bros. Advisors LPwith 4 more personsShare of class25.4%
- BlackRock, Inc.Share of class11.9%
- Vanguard Portfolio ManagementShare of class5.15%
| Holder | Kind of stake | Share of class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| Baker Bros. Advisors LPwith 4 more persons | 25.4% | 43.29M | Feb 26, 2026 | 13D/A | |
| BlackRock, Inc. | 11.9% | 19.88M | Feb 7, 2025 | 13G/A | |
| Vanguard Portfolio Management | 5.15% | 8.78M | Apr 28, 2026 | 13G |
Fell to 5% or less (3)
Holders whose latest filing says they hold 5% or less. After it they need not file again, so what they hold today is not known.
From the Schedule 13D and 13G filed with the SEC since Dec 18, 2024, when they became structured data. A holder who has filed nothing since then is not shown here. A 13D is updated within two business days of any material change, a 13G up to 45 days after the quarter of the change, so the shares are those of the filing. The large managers also appear in the 13Fs.
Well-known managers
Which of the about 30 investment managers we track held the shares at the quarter end, and what they changed from the quarter before.
- Point72 (Cohen)In the quarter-53%
- D.E. ShawIn the quarter+26%
- Renaissance TechnologiesIn the quarter-14%
- Citadel Advisors (Griffin)In the quarter-11%
- Millennium Mgmt (Englander)In the quarter+35%
- Bridgewater (Dalio)In the quarter-2.8%
- AQR CapitalIn the quarter-2.3%
| Manager | Shares | In the quarter | Value | % of their portfolio |
|---|---|---|---|---|
| Point72 (Cohen) | 1.14M | -53% | $23M | 0.04% |
| D.E. Shaw | 2.14M | +26% | $43M | 0.03% |
| Renaissance Technologies | 1.11M | -14% | $22M | 0.03% |
| Citadel Advisors (Griffin) | 1.93M | -11% | $39M | 0.02% |
| Millennium Mgmt (Englander) | 795.3K | +35% | $16M | 0.01% |
| Bridgewater (Dalio) | 48.9K | -2.8% | $1.0M | 0.00% |
| AQR Capital | 510.8K | -2.3% | $10M | 0.00% |
From the 13Fs managers file with the SEC up to 45 days after each quarter end. They show only long positions on that day, not short sales or what has changed since. No recent 13F: Pershing Square (Ackman), Scion (Burry).
Short interest
How many of the company's shares have been sold borrowed and not yet bought back, twice a month.
On Oct 15, 2026, 5.33% of its shares outstanding were held short, +9.9% since the report before.
- Shares held short
- 9.09M
- 5.33%
- Since the report before8.28M on Sep 30, 2026
- +9.9%
- 4.6
- 1.99M
- More days to cover thanof 4,578 US-listed companies with enough volume
- 55%
- Report date
- Oct 15, 2026
- Shares held short
- Oct 31, 2023: Shares held short 7.54M
- Nov 15, 2023: Shares held short 7.79M
- Nov 30, 2023: Shares held short 7.73M
- Dec 15, 2023: Shares held short 7.69M
- Dec 29, 2023: Shares held short 7.91M
- Jan 12, 2024: Shares held short 8.11M
- Jan 31, 2024: Shares held short 7.68M
- Feb 15, 2024: Shares held short 9.42M
- Feb 29, 2024: Shares held short 10.81M
- Mar 15, 2024: Shares held short 10.63M
- Mar 28, 2024: Shares held short 11.20M
- Apr 15, 2024: Shares held short 11.16M
- Apr 30, 2024: Shares held short 12.03M
- May 15, 2024: Shares held short 11.98M
- May 31, 2024: Shares held short 12.14M
- Jun 14, 2024: Shares held short 12.63M
- Jun 28, 2024: Shares held short 11.93M
- Jul 15, 2024: Shares held short 11.33M
- Jul 31, 2024: Shares held short 11.51M
- Aug 15, 2024: Shares held short 10.66M
- Aug 30, 2024: Shares held short 10.27M
- Sep 13, 2024: Shares held short 9.23M
- Sep 30, 2024: Shares held short 7.98M
- Oct 15, 2024: Shares held short 8.18M
- Oct 31, 2024: Shares held short 9.53M
- Nov 15, 2024: Shares held short 10.24M
- Nov 29, 2024: Shares held short 9.91M
- Dec 13, 2024: Shares held short 9.36M
- Dec 31, 2024: Shares held short 10.72M
- Jan 15, 2025: Shares held short 17.12M
- Jan 31, 2025: Shares held short 16.23M
- Feb 14, 2025: Shares held short 15.21M
- Feb 28, 2025: Shares held short 14.40M
- Mar 14, 2025: Shares held short 14.43M
- Mar 31, 2025: Shares held short 15.62M
- Apr 15, 2025: Shares held short 15.32M
- Apr 30, 2025: Shares held short 15.26M
- May 15, 2025: Shares held short 15.24M
- May 30, 2025: Shares held short 16.66M
- Jun 13, 2025: Shares held short 15.44M
- Jun 30, 2025: Shares held short 12.83M
- Jul 15, 2025: Shares held short 11.48M
- Jul 31, 2025: Shares held short 11.03M
- Aug 15, 2025: Shares held short 9.98M
- Aug 29, 2025: Shares held short 9.28M
- Sep 15, 2025: Shares held short 7.98M
- Sep 30, 2025: Shares held short 9.41M
- Oct 15, 2025: Shares held short 8.75M
- Oct 31, 2025: Shares held short 8.51M
- Nov 14, 2025: Shares held short 9.45M
- Nov 28, 2025: Shares held short 8.91M
- Dec 15, 2025: Shares held short 8.68M
- Dec 31, 2025: Shares held short 8.41M
- Jan 15, 2026: Shares held short 8.37M
- Jan 30, 2026: Shares held short 9.31M
- Feb 13, 2026: Shares held short 8.90M
- Feb 27, 2026: Shares held short 9.49M
- Mar 13, 2026: Shares held short 8.62M
- Mar 31, 2026: Shares held short 10.64M
- Apr 15, 2026: Shares held short 10.98M
- Apr 30, 2026: Shares held short 11.16M
- May 15, 2026: Shares held short 11.42M
- May 29, 2026: Shares held short 11.75M
- Jun 15, 2026: Shares held short 11.81M
- Jun 30, 2026: Shares held short 10.95M
- Jul 15, 2026: Shares held short 11.03M
- Jul 31, 2026: Shares held short 10.81M
- Aug 14, 2026: Shares held short 9.48M
- Aug 31, 2026: Shares held short 9.74M
- Sep 15, 2026: Shares held short 9.67M
- Sep 30, 2026: Shares held short 8.28M
- Oct 15, 2026: Shares held short 9.09M
As brokers report them to the regulator twice a month, mid-month and at month end, published about eight business days later. A short position is shares sold borrowed and not yet bought back. The share count is the one the company's market value is figured on, from its filings. Days to cover is the shares held short over the average daily volume of the weeks between two reports.
Short sales in daily trading27.0% of the shares in the last 14 sessions' reported trades were short sales.
In the last 14 sessions, 27.0% of the shares in the reported trades were short sales, against 48.5% in the 14 before.
- Last 14 sessionsOct 30, 2026 – Nov 18, 2026
- 27.0%
- The 14 beforeOct 12, 2026 – Oct 29, 2026
- 48.5%
- Change
- -21.5 pts
- Short sales a dayon average, of 1.38M shares
- 373.9K
- More than atof 3,656 US-listed companies, same days
- 3%
- Median of alleight in ten from 34.4% to 63.7%
- 50.3%
- Short sales
- Oct 12, 2026: Short sales 38%
- Oct 13, 2026: Short sales 64.5%
- Oct 14, 2026: Short sales 56%
- Oct 15, 2026: Short sales 45.3%
- Oct 16, 2026: Short sales 52.5%
- Oct 19, 2026: Short sales 46.7%
- Oct 20, 2026: Short sales 53%
- Oct 21, 2026: Short sales 56%
- Oct 22, 2026: Short sales 61.4%
- Oct 23, 2026: Short sales 55%
- Oct 26, 2026: Short sales 44.8%
- Oct 27, 2026: Short sales 35.4%
- Oct 28, 2026: Short sales 33%
- Oct 29, 2026: Short sales 30.9%
- Oct 30, 2026: Short sales 37.8%
- Nov 2, 2026: Short sales 46.3%
- Nov 3, 2026: Short sales 48.8%
- Nov 4, 2026: Short sales 27.7%
- Nov 5, 2026: Short sales 40%
- Nov 6, 2026: Short sales 56.3%
- Nov 9, 2026: Short sales 15.3%
- Nov 10, 2026: Short sales 10.4%
- Nov 11, 2026: Short sales 26.7%
- Nov 12, 2026: Short sales 44%
- Nov 13, 2026: Short sales 41.9%
- Nov 16, 2026: Short sales 32.4%
- Nov 17, 2026: Short sales 33.4%
- Nov 18, 2026: Short sales 32.2%
This is not the number of shares sold short today: it measures short sales within each day's trading, and only trades made off the exchanges. Much of it is market makers, who sell shares they do not have to fill buyers' orders and cover soon after, so for a heavily traded stock the share is often around half.
What the insiders hold
The shares each insider reports holding after their latest trade (Form 4), for those who traded on the market in the last three years.
- Baker Bros. Advisors LpDirectorDirectly43.27M
- Stephen DavisCEODirectly186.6K
- Mark C. SchneyerEVP, CHIEF FINANCIAL OFFICERDirectly71.3K
- Brendan TeehanEVP, COO, HEAD OF COMMERCIALDirectly62.1K
- Austin D. KimEVP,General Counsel, SecretaryDirectly46.9K
- Edmund HarriganDirectorDirectly43.1K
- Elizabeth A. GarofaloDirectorDirectly33.5K
- Adora NduDirectorDirectly32.9K
- Laura BregeDirectorDirectly23.2K
- Elizabeth H.Z. ThompsonEVP, Head of Research & DevDirectly19.0K
- Adams Catherine OwenChief Executive OfficerDirectly14.8K
- James KiharaPRINCIPAL ACCOUNTING OFFICERDirectly13.1K
- James M DalyDirectorDirectly12.1K
- Jennifer J RhodesEVP, CHIEF LEGAL OFFICER, SECDirectly11.3K
- Jonathan PooleDirectorDirectly2,010
| Person | Directly | Indirectly | After the trade of | Filing |
|---|---|---|---|---|
| Baker Bros. Advisors LpDirector | 43.27M | – | May 29, 2026 | Form 4 |
| Stephen DavisCEO | 186.6K | – | Aug 19, 2024 | Form 4 |
| Mark C. SchneyerEVP, CHIEF FINANCIAL OFFICER | 71.3K | – | Oct 30, 2026 | Form 4 |
| Brendan TeehanEVP, COO, HEAD OF COMMERCIAL | 62.1K | – | Nov 19, 2024 | Form 4 |
| Austin D. KimEVP,General Counsel, Secretary | 46.9K | – | Jan 8, 2024 | Form 4 |
| Edmund HarriganDirector | 43.1K | – | May 29, 2026 | Form 4 |
| Elizabeth A. GarofaloDirector | 33.5K | – | May 29, 2026 | Form 4 |
| Adora NduDirector | 32.9K | – | May 29, 2026 | Form 4 |
| Laura BregeDirector | 23.2K | – | May 29, 2026 | Form 4 |
| Elizabeth H.Z. ThompsonEVP, Head of Research & Dev | 19.0K | – | Jul 30, 2026 | Form 4 |
| Adams Catherine OwenChief Executive Officer | 14.8K | – | Mar 25, 2026 | Form 4 |
| James KiharaPRINCIPAL ACCOUNTING OFFICER | 13.1K | – | Jun 26, 2026 | Form 4 |
| James M DalyDirector | 12.1K | – | May 29, 2026 | Form 4 |
| Jennifer J RhodesEVP, CHIEF LEGAL OFFICER, SEC | 11.3K | – | Mar 25, 2026 | Form 4 |
| Jonathan PooleDirector | 2,010 | – | May 29, 2026 | Form 4 |
A lower bound: it counts only the 15 officers and directors with a market trade since Nov 20, 2023. Anyone who neither bought nor sold since is not here, whatever they hold. The share is against the share count on the latest 10-K's cover.
The ETFs that hold it
Which of the 345 US equity ETFs we track hold the stock, and at what weight, from the funds' N-PORT filings.
- XBIState Street(R) SPDR(R) S&P(R) Biotech ETFWeight in the fund0.94%
- LABUDirexion Daily S&P Biotech Bull 3X SharesWeight in the fund0.71%
- IJTiShares S&P Small-Cap 600 Growth ETFWeight in the fund0.35%
- IBBiShares Biotechnology ETFWeight in the fund0.33%
- IWOiShares Russell 2000 Growth ETFWeight in the fund0.20%
- SPSMState Street(R) SPDR(R) Portfolio S&P 600(TM) Small Cap ETFWeight in the fund0.17%
- IJRiShares Core S&P Small-Cap ETFWeight in the fund0.17%
- VTWOVanguard Russell 2000 Index FundWeight in the fund0.12%
- IWMiShares Russell 2000 ETFWeight in the fund0.10%
- DFASDimensional U.S. Small Cap ETFWeight in the fund0.09%
26 of the 345 ETFs we track, not of every ETF on the market. The ten largest weights. Positions as each fund filed them in its latest N-PORT.
Institutional investors by quarter
Every manager that reports positions to the SEC (Form 13F), quarter by quarter: how many hold the stock, how many shares and dollars between them, and who entered, left, added or trimmed during the quarter.
- Managers
- Q3 2025: Managers 336
- Q4 2025: Managers 338
- Q1 2026: Managers 346
- Q2 2026: Managers 352
Institutional investors by quarter
The fund managers holding ACAD, quarter by quarter, from Q1 2013 to Q2 2025, 50 more quarters
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 12 quarters.
Q2 2026: 352 managers held 169M shares, worth $4.3B. During the quarter 49 opened a position, 43 closed one, 131 added and 110 trimmed.
The largest holders, Q2 2026
- Baker Bros. AdvisorsIn the quarter
- BlackRockIn the quarter+4.5%
- State StreetIn the quarter+8.9%
- Vanguard Portfolio ManagementIn the quarter+1.9%
- Rtw InvestmentsIn the quarter
- Vanguard Capital ManagementIn the quarter+1.8%
- Dimensional Fund AdvisorsIn the quarter+17%
- Geode Capital ManagementIn the quarter-3.1%
- Palo Alto InvestorsIn the quarter-0.3%
- Goldman Sachs GroupIn the quarter+66%
| Manager | Shares | In the quarter | Value |
|---|---|---|---|
| Baker Bros. Advisors | 42.91M | $1.1B | |
| BlackRock | 22.52M | +4.5% | $570M |
| State Street | 9.08M | +8.9% | $230M |
| Vanguard Portfolio Management | 8.84M | +1.9% | $224M |
| Rtw Investments | 7.14M | $181M | |
| Vanguard Capital Management | 5.76M | +1.8% | $146M |
| Dimensional Fund Advisors | 3.69M | +17% | $93M |
| Geode Capital Management | 3.36M | -3.1% | $85M |
| Palo Alto Investors | 2.86M | -0.3% | $72M |
| Goldman Sachs Group | 2.58M | +66% | $65M |
From the SEC's Form 13F data sets, Q3 2025 to Q2 2026: the long positions of every manager with more than $100 million under management, as filed up to 45 days after each quarter end. Short positions and options are not in them. Shares as reported each quarter, not adjusted for splits. The stock is matched by its CUSIP, through the SEC's fails-to-deliver files.
Pay against performance, the say-on-pay vote, buybacks by quarter and trading plans are read for S&P 500 companies only.
The full analysis
What do ACADIA Pharmaceuticals's filings show?
Who buys and sells is one part of ACADIA Pharmaceuticals's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Have ACAD's insiders bought or sold?
From May 27, 2026 to Oct 30, 2026 ACADIA Pharmaceuticals's insiders bought 0 and sold $1.5M of shares on the market. 92% of the sales were under set 10b5-1 plans.
Which well-known managers hold ACAD?
7 of the managers we track held the shares on Sep 30, 2026. The largest position was D.E. Shaw's, worth $43M.
Is every insider transaction a purchase or a sale?
No. Many are part of their pay: share awards, option exercises and shares the company keeps for the tax. Only code P is a purchase with their own money, and code S a sale on the market.
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.